Timolol Hemihydrate NDC 70069-698

NDC codes

FDA NDC Directory

Product NDC (as listed)70069-698Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70069-0698Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70069-698-01	70069069801	1 BOTTLE in 1 CARTON (70069-698-01) / 15 mL in 1 BOTTLEMarketed from Oct 31, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Timolol Hemihydrate
Generic name (nonproprietary): timolol hemihydrate
Active ingredients: Timolol anhydrous — 5 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Somerset Therapeutics, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216654
Marketing start: Oct 31, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 70069-698_c1213979-d6ff-44c2-ad97-1de99ddcf8d2SPL ID c1213979-d6ff-44c2-ad97-1de99ddcf8d2SPL set ID cebc9a5e-0bdb-4f23-9b2c-cde543b62fb6RxCUI 2702393UNII 5JKY92S7BRUPC 0370069697016, 0370069698013, 0370069696019
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470069069801 followed by a unit qualifier and the quantity

Package 70069-0698-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 31, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Timolol ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216654

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216654
Product	Strength	Form · route	Labeler	Product NDC
Timolol Hemihydrate	Timolol anhydrous 5 mg/mL	Solution/ dropsOphthalmic	Somerset Therapeutics, LLC	70069-697
Timolol Hemihydrate	Timolol anhydrous 5 mg/mL	Solution/ dropsOphthalmic	Somerset Therapeutics, LLC	70069-696